For the second year in a row, Corindus participated and exhibited in the SCAI Fellows Course, which took place December 6-9th in Las Vegas, generating a great deal of buzz for robotic-assisted PCI. The show is attended by interventional and structural fellows from across the globe.
It was exciting to see the interest and excitement around CorPath amongst the attendees at the conference, who immediately saw the protective value that CorPath provides, and were enthusiastic about the clinical potential of robotics in the cath lab. Fellows queued up throughout the meeting to complete our C.A.S.E (CorPath Angioplasty Simulated Experience) Certification, which gives physicians the opportunity to perform a complex robotic-assisted PCI from the interventional cockpit on an advanced interventional procedure simulator. The interventionalists in training had very thoughtful questions on how the technology would impact their future practice and were visibly excited about how this could greatly reduce the occupational hazards in their careers, potentially preventing some of the risks associated with working in the cath lab.
“This is really exciting, I am going to look out for a hospital that makes safety a priority and hopefully has this technology as I make my decision on choosing a job,” said one. Others found the interface very intuitive and treated multiple lesions robotically during their simulated experience. Many others immediately saw the wide array of potential applications in that may be available in the future. It was particularly encouraging to see how these future cath lab leaders were able to envision how robotics will integrate into their practice.
Corindus Booth at SCAI Fellows Course
In addition, the conference featured talks on “Radiation Safety in the Cath Lab” by Dr. Charles Chambers and “The Future of Cath Lab” by Dr. Ehtisham Mahmud of the University of California San Diego, who spoke about measures to reduce radiation exposure and innovative technologies, such as CorPath, that will shape the future of the cath lab.
We, at Corindus, are very enthused by the interest and openness shown by the future users of our technology. We know that this excitement requires us to rise to the occasion and continue to innovate and do all that we can to make the future safer for our physicians.